Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement

被引：39

作者：

Le Pechoux, Cecile ^{[1
]}

Dunant, Ariane

Pignon, Jean-Pierre

De Ruysscher, Dirk

Mornex, Francise

Senan, Suresh

Casas, Francesc

Price, Allan

Milleron, Bernard

机构：

[1] Inst Gustave Roussy, Dept Radiotherapy, F-94805 Villejuif, France

[2] Inst Gustave Roussy, Dept Biostat, F-94805 Villejuif, France

[3] Univ Limburg, Acad Hosp Maastricht, GROW MAASTRO Clin, Maastricht, Netherlands

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 07期

关键词：

D O I：

10.1200/JCO.2006.09.6263

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E10 / E11

页数：2

共 11 条

[1] Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer:: 5-year follow-up of a phase II study [J].

Betticher, DC ;

Schmitz, SFH ;

Tötsch, M ;

Hansen, E ;

Joss, C ;

von Briel, C ;

Schmid, R ;

Pless, M ;

Habicht, J ;

Roth, AD ;

Spiliopoulos, A ;

Stahel, R ;

Weder, W ;

Stupp, R ;

Egli, F ;

Furrer, M ;

Honegger, H ;

Wernli, M ;

Cerny, T ;

Ris, HB .

BRITISH JOURNAL OF CANCER, 2006, 94 (08) :1099-1106

[2] Postoperative radiotherapy in non-small-cell lung cancer warrants further exploration in the era of adjuvant chemotherapy and conformal radiotherapy [J].

Bonner, James A. ;

Spencer, Sharon A. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) :2978-2980

[3]

Burdett S, 1998, LANCET, V352, P257

[4] Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]):: a randomised controlled trial [J].

Douillard, Jean-Yves ;

Rosell, Rafael ;

De Lena, Mario ;

Carpagnano, Francesco ;

Ramlau, Rodryg ;

Gonzales-Larriba, Jose Luis ;

Grodzki, Tornasz ;

Pereira, Jose Rodrigues ;

Le Groumellec, Alain ;

Lorusso, Vito ;

Clary, Claude ;

Torres, Antonio J. ;

Dahabreh, Jabrail ;

Souquet, Pierre-Jean ;

Astudillo, Julio ;

Fournel, Pierre ;

Artal-Cortes, Angel ;

Jassem, Jacek ;

Koubkova, Leona ;

His, Patricia ;

Riggi, Marcella ;

Hurteloup, Patrick .

LANCET ONCOLOGY, 2006, 7 (09) :719-727

[5] Postoperative radiotherapy for stage II or III non-small-cell lung cancer using th surveillance, epidemiology, and end results database [J].

Lally, Brian E. ;

Zelterman, Daniel ;

Colasanto, Joseph M. ;

Haffty, Bruce G. ;

Detterbeck, Frank C. ;

Wilson, Lynn D. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) :2998-3006

[6] Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer [J].

Le Chevalier, T ;

Arriagada, R ;

Le Péchoux, C ;

Grunenwald, D ;

Dunant, A ;

Pignon, JP ;

Tarayre, M ;

Abratt, R ;

Arriagada, R ;

Bergman, B ;

Gralla, R ;

Grunenwald, D ;

Le Chevalier, T ;

Orlowski, T ;

Papadakis, E ;

Pinel, MIS ;

Araujo, C ;

Della Torre, H ;

de Solchaga, MM ;

Abdi, E ;

Blum, R ;

Ball, D ;

Basser, R ;

De Boer, R ;

Bishop, J ;

Brigham, B ;

Davis, S ;

Fox, D ;

Richardson, G ;

Wyld, D ;

Pirker, R ;

Humblet, Y ;

Delaunois, L ;

Van Meerbeeck, JP ;

Germonpre, P ;

Vansteenkiste, J ;

Nackaerts, K ;

Pinel, MIS ;

Vauthier, G ;

Younes, RN ;

Arriagada, R ;

Baeza, R ;

Carvajal, P ;

Kleinman, S ;

Orlandi, L ;

Castro, C ;

Godoy, J ;

Kosatova, K ;

Gaafar, R ;

Azarian, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04) :351-360

[7] Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma [J].

Machtay, M ;

Lee, JH ;

Shrager, JB ;

Kaiser, LR ;

Glatstein, E .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) :3912-3917

[8] Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy [J].

Overgaard, M ;

Hansen, PS ;

Overgaard, J ;

Rose, C ;

Andersson, M ;

Bach, F ;

Kjaer, M ;

Gadeberg, CC ;

Mouridsen, HT ;

Jensen, MB ;

Zedeler, K .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (14) :949-955

[9] Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer [J].

Ragaz, J ;

Jackson, SM ;

Le, N ;

Plenderleith, IH ;

Spinelli, JJ ;

Basco, VE ;

Wilson, KS ;

Knowling, MA ;

Coppin, CML ;

Paradis, M ;

Coldman, AJ ;

Olivotto, IA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (14) :956-962

[10] Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590 [J].

Wakelee, HA ;

Stephenson, P ;

Keller, SM ;

Wagner, H ;

Herskovic, A ;

Komaki, R ;

Marks, RS ;

Perry, MC ;

Livingston, RB ;

Johnson, DH .

LUNG CANCER, 2005, 48 (03) :389-397

← 1 2 →